IRIS
SOTA, JURGEN
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.642
EU - Europa 5.566
AS - Asia 4.627
SA - Sud America 890
AF - Africa 274
OC - Oceania 17
Continente sconosciuto - Info sul continente non disponibili 1
Totale 18.017
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.492
RU - Federazione Russa 1.483
SG - Singapore 1.444
CN - Cina 1.227
GB - Regno Unito 1.136
IT - Italia 974
BR - Brasile 718
VN - Vietnam 568
IE - Irlanda 528
HK - Hong Kong 352
FR - Francia 294
SE - Svezia 270
BD - Bangladesh 251
KR - Corea 249
DE - Germania 242
FI - Finlandia 176
UA - Ucraina 175
IN - India 146
ZA - Sudafrica 131
TR - Turchia 83
CA - Canada 75
AR - Argentina 57
NL - Olanda 56
IQ - Iraq 52
MX - Messico 49
PL - Polonia 45
JP - Giappone 44
PK - Pakistan 39
ES - Italia 32
EC - Ecuador 29
AT - Austria 27
BE - Belgio 26
KE - Kenya 26
CI - Costa d'Avorio 24
ID - Indonesia 23
CZ - Repubblica Ceca 22
MA - Marocco 22
VE - Venezuela 22
EG - Egitto 18
AU - Australia 17
CO - Colombia 17
IR - Iran 16
SA - Arabia Saudita 16
UZ - Uzbekistan 15
DZ - Algeria 14
NG - Nigeria 14
CL - Cile 13
NP - Nepal 13
PE - Perù 13
AE - Emirati Arabi Uniti 11
JO - Giordania 11
PH - Filippine 10
TN - Tunisia 10
CH - Svizzera 8
JM - Giamaica 8
LB - Libano 8
PY - Paraguay 8
LT - Lituania 7
MY - Malesia 7
RO - Romania 7
AL - Albania 6
CR - Costa Rica 6
DK - Danimarca 6
UY - Uruguay 6
EE - Estonia 5
IL - Israele 5
RS - Serbia 5
AM - Armenia 4
AZ - Azerbaigian 4
BH - Bahrain 4
BO - Bolivia 4
BY - Bielorussia 4
ET - Etiopia 4
GR - Grecia 4
HU - Ungheria 4
LV - Lettonia 4
TH - Thailandia 4
GY - Guiana 3
NI - Nicaragua 3
NO - Norvegia 3
OM - Oman 3
PS - Palestinian Territory 3
PT - Portogallo 3
TT - Trinidad e Tobago 3
CG - Congo 2
CY - Cipro 2
KG - Kirghizistan 2
KW - Kuwait 2
KZ - Kazakistan 2
LU - Lussemburgo 2
MD - Moldavia 2
MK - Macedonia 2
PA - Panama 2
TG - Togo 2
TM - Turkmenistan 2
TW - Taiwan 2
AO - Angola 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BW - Botswana 1
Totale 17.998
Salva come PNG Salva come JPEG
Città #
Dallas 1.194
Southend 965
Singapore 828
Dublin 517
Ashburn 457
Santa Clara 451
Moscow 415
Fairfield 405
Hefei 380
San Jose 354
Hong Kong 327
Beijing 253
Seoul 249
Woodbridge 227
Siena 189
Chandler 178
Ho Chi Minh City 178
New York 178
Houston 177
Menlo Park 176
Los Angeles 162
Wilmington 154
Ann Arbor 150
Seattle 145
Cambridge 138
Hanoi 136
Jacksonville 136
The Dalles 136
Milan 133
Council Bluffs 127
Lauterbourg 127
Johannesburg 118
Helsinki 105
Princeton 85
Munich 83
Rome 71
São Paulo 66
Dearborn 60
Buffalo 59
Bengaluru 52
Chicago 50
Dong Ket 49
Orem 48
Redondo Beach 45
Lappeenranta 43
Nanjing 43
San Mateo 42
Warsaw 34
Da Nang 33
Florence 33
London 33
Nuremberg 31
Frankfurt am Main 30
Tokyo 30
Shanghai 29
San Diego 28
Boardman 26
Guangzhou 26
Abidjan 24
Brussels 24
Chennai 23
Izmir 23
Montreal 23
Istanbul 22
San Francisco 22
Columbus 21
Brooklyn 20
Turku 20
Mexico City 19
Portsmouth 19
Rio de Janeiro 19
Düsseldorf 18
Amsterdam 17
Denver 17
Toronto 17
Nanchang 16
Naples 16
Atlanta 15
Boston 15
Campinas 15
Haiphong 15
Manchester 15
Stockholm 15
Washington 15
Baghdad 14
Tashkent 14
Abuja 13
Belo Horizonte 13
Charlotte 13
Jinan 13
Mumbai 13
Hebei 12
Phoenix 12
Shenyang 12
Amman 11
Ankara 11
Bari 11
Biên Hòa 11
Jiaxing 11
Nairobi 11
Totale 11.674
Salva come PNG Salva come JPEG
Nome #
Cumulative retention rate of adalimumab in patients with Behçet's disease-related uveitis: A four-year follow-up study 348
Drug Retention Rate and Predictive Factors of Drug Survival for Interleukin-1 Inhibitors in Systemic Juvenile Idiopathic Arthritis 333
Comparative efficacy between adalimumab and infliximab in the treatment of non-infectious intermediate uveitis, posterior uveitis, and panuveitis: a retrospective observational study of 107 patients 330
Biological therapies for the treatment of Behçet's disease-related uveitis beyond TNF-alpha blockade: a narrative review 314
Long-term retention rates of adalimumab and infliximab in non-infectious intermediate, posterior, and panuveitis 314
Auditory involvement in Behcet’s disease: relationship with demographic, clinical, and therapeutic characteristics 312
Ten-Year Retention Rate of Infliximab in Patients with Behçet’s Disease-Related Uveitis 310
Efficacy of adalimumab and infliximab in recalcitrant retinal vasculitis inadequately responsive to other immunomodulatory therapies 290
Quality of life impairment in Behçet’s disease and relationship with disease activity: a prospective study 271
The diagnostic evaluation of patients with a suspected hereditary periodic fever syndrome: experience from a referral center in Italy 263
Behçet’s syndrome in Italy: a detailed retrospective analysis of 396 cases seen in 3 tertiary referral clinics 262
Rapid and Sustained Efficacy of Golimumab in the Treatment of Multirefractory Uveitis Associated with Behçet’s Disease 247
A novel grey scale and Power Doppler ultrasonographic score for idiopathic inflammatory myopathies: Siena Myositis Ultrasound Grading Scale 240
Correlation of Serum Amyloid-A Levels, Clinical Manifestations, Treatment, and Disease Activity in Patients with Behçet's Disease 240
The Presence of Uveitis Is Associated with a Sustained Response to the Interleukin (IL)-1 Inhibitors Anakinra and Canakinumab in Behçet's Disease 239
Treatment options for periodic fever, aphthous stomatitis, pharyngitis, and cervical adenitis (PFAPA) syndrome in children and adults: a narrative review 237
Safety profile of the interleukin-1 inhibitors anakinra and canakinumab in real-life clinical practice: a nationwide multicenter retrospective observational study 237
Predictors of sustained clinical response in patients with Behçet’s disease-related uveitis treated with infliximab and adalimumab 233
Impact of Uveitis on Quality of Life: A Prospective Study from a Tertiary Referral Rheumatology-Ophthalmology Collaborative Uveitis Center in Italy 231
The eye involvement in monogenic autoinflammatory diseases: Literature review and update 230
Orbital/ocular inflammatory involvement in VEXAS syndrome: Data from the international AIDA network VEXAS registry 223
A patient-driven registry on Behçet’s disease: the AIDA for patients pilot project 219
Efficacy and safety of anakinra in tumor necrosis factor receptor-associated periodic syndrome (TRAPS) complicated by severe renal failure: a report after long-term follow-up and review of the literature 215
Development and implementation of the AIDA international registry for patients with non-infectious uveitis 213
Axial spondyloarthritis in patients with recurrent fever attacks: data from the AIDA network registry for undifferentiated autoInflammatory diseases (USAIDs) 211
IL-6 blockade in the management of non-infectious uveitis 206
Development and implementation of the AIDA international registry for patients with Schnitzler's syndrome 204
Anakinra drug retention rate and predictive factors of long-term response in systemic juvenile idiopathic arthritis and adult onset still disease 203
Clinical and laboratory features associated with macrophage activation syndrome in Still’s disease: data from the international AIDA Network Still’s Disease Registry 195
Long-Term Outcomes of Behçet's Syndrome-Related Uveitis: A Monocentric Italian Experience 195
Development and implementation of the AIDA International Registry for patients with Behçet's disease 194
Clinical profile and evolution of patients with juvenile-onset Behçet's syndrome over a 25-year period: insights from the AIDA network 192
The emerging role of interleukin (IL)-1 in the pathogenesis and treatment of inflammatory and degenerative eye diseases 191
Canakinumab as first-line biological therapy in Still’s disease and differences between the systemic and the chronic-articular courses: real-life experience from the international AIDA registry 188
Relapsing Polychondritis: an Update on Pathogenesis, Clinical Features, Diagnostic Tools, and Therapeutic Perspectives 182
Development and implementation of the AIDA international registry for patients with non-infectious scleritis 178
Comparison of Early vs. Delayed Anakinra Treatment in Patients With Adult Onset Still's Disease and Effect on Clinical and Laboratory Outcomes 177
Dry eye disease and spondyloarthritis: expanding the spectrum of systemic inflammatory disorders associated with ocular surface disease. Data from the international AIDA Network Spondyloarthritis Registry 172
Prompt Clinical Response to Secukinumab in Patients with Axial Spondyloarthritis: Real Life Observational Data from Three Italian Referral Centers 170
Influence of gender on Behçet's disease phenotype and irreversible organ damage: Data from the International AIDA Network Behçet's Disease Registry 169
Impact of HLA-B51 on Uveitis and Retinal Vasculitis: Data from the AIDA International Network Registries on Ocular Inflammatory Disorders 167
Role of Colchicine Treatment in Tumor Necrosis Factor Receptor Associated Periodic Syndrome (TRAPS): Real-Life Data from the AIDA Network 167
Adalimumab Monotherapy or Combination Therapy With Methotrexate in Paediatric Uveitis: Data From the AIDA Network Uveitis Registry 164
Efficacy and safety of certolizumab pegol and golimumab in the treatment of non-infectious uveitis 164
Anakinra and canakinumab for patients with R92Q-associated autoinflammatory syndrome: a multicenter observational study from the AIDA Network 159
Anti-dense fine speckled 70 antibodies in primary Sjögren's syndrome 158
Impact of HLA-B51 on uveitis and retinal vasculitis: data from the AIDA International Network Registries on ocular inflammatory disorders 155
Development and Implementation of the AIDA International Registry for Patients With Undifferentiated Systemic AutoInflammatory Diseases 152
Accrual of organ damage in Behçet’s syndrome: trajectory, associated factors, and impact on patients’ quality of life over a 2-year prospective follow-up study 152
Autoinflammatory diseases and the kidney 150
Comparing biologic options for the management of Behcet's disease-related uveitis 149
Ocular Manifestations in Juvenile Behçet’s Disease: A Registry-Based Analysis from the AIDA Network 148
Serum immunoglobulin D levels in patients with Behçet's disease according to different clinical manifestations 147
Epidemiological profile of non-infectious uveitis from the rheumatologist's perspective: a survey from two tertiary referral centres in Italy 146
Biologic drugs in the treatment of polyarteritis nodosa and deficit of adenosine deaminase 2: a narrative review 144
Development and implementation of the AIDA International Registry for patients with Periodic Fever, Aphthous stomatitis, Pharyngitis, and cervical Adenitis syndrome 143
The role of biosimilars in uveitis: Long-term real-world outcomes of the switch from original to biosimilar TNF-alpha inhibitors 142
The diagnostic role of pathergy test in patients with Behçet’s disease from the Western Europe 140
Unfolding dermatologic spectrum of Behçet’s disease in Italy: real-life data from the International AIDA Network Behçet’s disease Registry 140
The Role of Multimodality Imaging in Monitoring Disease Activity and Therapeutic Response to Tocilizumab in Giant Cell Arteritis 140
Development and Implementation of the AIDA International Registry for Patients With VEXAS Syndrome 139
Efficacy and safety of conventional disease-modifying antirheumatic drugs in VEXAS syndrome: real-world data from the international AIDA network 137
Development and implementation of the AIDA international registry for patients with Still's disease 136
Clinical Features at Onset and Genetic Characterization of Pediatric and Adult Patients with TNF- α Receptor - Associated Periodic Syndrome (TRAPS): A Series of 80 Cases from the AIDA Network 136
Biotechnological agents for patients with tumor necrosis factor receptor associated periodic syndrome—therapeutic outcome and predictors of response: real-life data from the AIDA Network 135
Musculoskeletal manifestations in children with Behçet's syndrome: data from the AIDA Network Behçet's Syndrome Registry 134
The clinical assessment of lung involvement in patients with Still’s disease, results from the multicentre international AIDA Network Still's Disease Registry 134
Development and implementation of the international AIDA network spondylarthritis registry 133
Efficacy and safety of adalimumab in pediatric non-infectious non-anterior uveitis: real-life experience from the International AIDA Network Uveitis Registry 132
Efficacy and safety of abatacept in a patient with rheumatoid arthritis and concomitant Staphylococcus aureus osteomyelitis 131
Updated overview of molecular pathways involved in the most common monogenic autoinflammatory diseases 131
Effectiveness and Safety of Biosimilars in Pediatric Non-infectious Uveitis: Real-Life Data from the International AIDA Network Uveitis Registry 128
Biologic therapies and small molecules for the management of non-infectious scleritis: a narrative review 125
Risk for cancer development in familial Mediterranean fever and associated predisposing factors: an ambidirectional cohort study from the international AIDA network registries 123
Efficacy of anti-tumour necrosis factor-α monoclonal antibodies in patients with non-infectious anterior uveitis 123
Still’s disease continuum from childhood to elderly: data from the international AIDA Network Still’s disease registry 122
Efficacy of monoclonal anti-tumour necrosis factor-α antibodies in uveitic macular oedema 122
Power and spectral Doppler ultrasound in suspected active sacroiliitis: A comparison with magnetic resonance imaging as gold standard 121
The role of biologic agents in the management of pediatric-onset noninfectious posterior scleritis 121
The current status of biological treatment for uveitis 121
Musculoskeletal manifestations in hereditary periodic fever syndromes 120
Tocilizumab Vs Methotrexate in a Cohort of Patients Affected by Active GCA: A Comparative Clinical and Ultrasonographic Study 119
Efficacy and safety of Janus kinase inhibitors in non-infectious inflammatory ocular diseases: a prospective cohort study from the international AIDA network registries 117
Polidistrectual videocapillaroscopic evaluation in a patient with prolidase deficiency 115
Long-term retention rate of anakinra in adult onset Still’s disease and predictive factors for treatment response 115
Efficacy and safety of tocilizumab in adult-onset Still's disease: real-life experience from the international AIDA registry 114
Efficacy and Safety of Upadacitinib in Rheumatoid Arthritis: Real-Life Experience from a Prospective Longitudinal Multicentric Study 113
Real-Life Data on the Efficacy of Canakinumab in Patients with Adult-Onset Still's Disease 112
Drug survival of anakinra and canakinumab in monogenic autoinflammatory diseases: observational study from the International AIDA Registry 107
Efficacy of canakinumab in patients with Still’s disease across different lines of biologic therapy: real-life data from the International AIDA Network Registry for Still’s Disease 107
Preliminary data revealing efficacy of Streptococcus salivarius K12 (SSK12) in Periodic Fever, Aphthous stomatitis, Pharyngitis, and cervical Adenitis (PFAPA) syndrome: a multicenter study from the AIDA Network PFAPA syndrome registry 106
Serum Interleukin-36 α as a Candidate Biomarker to Distinguish Behçet’s Syndrome and Psoriatic Arthritis 105
New potential weapons for refractory scleritis in the era of targeted therapy 103
Imaging findings in patients with axial spondyloarthritis presenting with recurrent fever attacks: data from the international AIDA network spondyloarthritis registry 102
IL-1 targeting agents in Schnitzler syndrome: a multicentre, real-world study from the international AIDA Network Schnitzler Registry 100
Long-Term Effectiveness of Secukinumab in Patients with Axial Spondyloarthritis 100
Predictors of proteinuria, amyloidosis and kidney failure in familial Mediterranean fever: data from the International AIDA Network Registry 98
Differential serum levels of interleukin-37 in patients with tumour necrosis factor receptor-associated periodic syndrome (TRAPS) 98
The autoinflammatory diseases alliance registry of monogenic autoinflammatory diseases 93
Empowering patients in the therapeutic decision-making process: a glance into Behçet's syndrome 87
Totale 17.120
Salva come PNG Salva come JPEG
Categoria #
all - tutte 53.087
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 53.087
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021119 0 0 0 0 0 0 0 0 0 0 0 119
2021/2022822 72 112 64 55 45 9 36 32 47 78 104 168
2022/2023804 57 71 132 94 57 153 28 63 72 12 37 28
2023/20241.062 39 24 91 56 32 298 302 55 12 18 48 87
2024/20253.577 289 145 354 151 406 209 164 200 272 183 318 886
2025/20268.791 645 1.233 1.057 1.111 1.439 305 1.077 303 330 506 429 356
Totale 18.445